The Centers for Medicare & Medicaid Services issued an interim final rule imposing work-requirement conditions on Medicaid eligibility [1, 2].
Advocates said these changes could cause patients with rare diseases to lose essential health coverage if they cannot meet the new employment criteria [1, 2]. Because many rare diseases cause significant disability, critics said the requirements ignore the medical realities of the population they serve.
The National Organization for Rare Disorders and its CEO, Pamela Gavin, said they have raised alarms over the potential impact on vulnerable beneficiaries [1, 2]. The rule is scheduled to take effect in January 2027 [3].
In Pennsylvania, advocates said hundreds of thousands of residents could be affected by the cuts and requirements [3]. The shift in eligibility rules creates a precarious situation for those whose conditions make traditional employment impossible.
The policy has already faced significant legal opposition. Twenty-five states and Washington, D.C. have joined a lawsuit against the rule [4]. This represents approximately half of the states in the U.S. challenging the requirements [4].
Medicaid serves as a primary source of insurance for millions of low-income individuals, including those with lifelong chronic conditions. For patients with rare diseases, the loss of this coverage often means losing access to specialized medications, and treatments that are otherwise unaffordable.
“The rule is scheduled to take effect in January 2027”
The implementation of work requirements represents a shift toward a more restrictive eligibility model for Medicaid. By linking healthcare access to employment, the government may reduce program spending, but rare-disease advocates suggest this creates a systemic gap where the sickest patients—those least capable of working—are the most likely to be disqualified from the system.
